NO20040738L - Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion. - Google Patents

Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.

Info

Publication number
NO20040738L
NO20040738L NO20040738A NO20040738A NO20040738L NO 20040738 L NO20040738 L NO 20040738L NO 20040738 A NO20040738 A NO 20040738A NO 20040738 A NO20040738 A NO 20040738A NO 20040738 L NO20040738 L NO 20040738L
Authority
NO
Norway
Prior art keywords
ethoxyl
thiazolidine
dione
pyridyl
benzyl
Prior art date
Application number
NO20040738A
Other languages
English (en)
Inventor
Jai Patel
Jeffrey Roger Granett
Paul Nigel Wray
Ross Hamish
Robin Price
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Publication of NO20040738L publication Critical patent/NO20040738L/no
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20040738A 1997-06-05 2004-02-20 Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion. NO20040738L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition
PCT/EP1998/003478 WO1998055122A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
NO20040738L true NO20040738L (no) 2000-02-02

Family

ID=26311662

Family Applications (2)

Application Number Title Priority Date Filing Date
NO995938A NO995938L (no) 1997-06-05 1999-12-03 Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
NO20040738A NO20040738L (no) 1997-06-05 2004-02-20 Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO995938A NO995938L (no) 1997-06-05 1999-12-03 Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion

Country Status (29)

Country Link
EP (1) EP0998284A1 (no)
JP (1) JP2001521553A (no)
KR (1) KR20010013410A (no)
CN (3) CN1112926C (no)
AP (1) AP1214A (no)
AR (2) AR008198A1 (no)
AU (1) AU8215098A (no)
BG (1) BG104048A (no)
BR (1) BR9810405A (no)
CA (2) CA2292629C (no)
CO (1) CO4940400A1 (no)
DZ (1) DZ2510A1 (no)
EA (1) EA002384B1 (no)
GB (1) GB9711683D0 (no)
HU (1) HUP0004070A3 (no)
ID (1) ID24264A (no)
IL (1) IL133074A0 (no)
MX (1) MXPA99011322A (no)
NO (2) NO995938L (no)
NZ (2) NZ523725A (no)
OA (1) OA11306A (no)
PE (1) PE78899A1 (no)
PL (1) PL337201A1 (no)
SK (1) SK164899A3 (no)
TR (2) TR200002790T2 (no)
TW (1) TW570797B (no)
UY (1) UY25032A1 (no)
WO (1) WO1998055122A1 (no)
ZA (2) ZA9811572B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
DE60004658T2 (de) 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
DE06252444T8 (de) * 2006-05-09 2009-03-19 Teva Pharmaceutical Industries Ltd. 2-N-{5-[[4-[2-(Methyl-2-pyridinylamino)-ethoxy]-phenyl]-methyl]-2,4-thiazolidindion}-bernsteinsäure, Verfahren zur Herstellung und Zusammensetzungen mit Rosiglitazonmaleat
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
MX9603338A (es) * 1994-02-10 1997-03-29 Smithkline Beecham Plc Uso de sensibilizadores a la insulina para tratar enfermedades renales.
JPH11510508A (ja) * 1995-08-10 1999-09-14 ワーナー−ランバート・コンパニー インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法
WO1997018811A1 (en) * 1995-11-17 1997-05-29 Warner-Lambert Company A method of treating myotonic dystrophy
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
EP0921798A1 (en) * 1996-07-12 1999-06-16 Smithkline Beecham Plc Novel treatment of leptine resistance

Also Published As

Publication number Publication date
AP9901696A0 (en) 1999-12-31
EP0998284A1 (en) 2000-05-10
AU8215098A (en) 1998-12-21
BR9810405A (pt) 2000-08-29
SK164899A3 (en) 2000-11-07
KR20010013410A (ko) 2001-02-26
NZ513922A (en) 2001-09-28
CN1112926C (zh) 2003-07-02
CA2292629C (en) 2004-01-06
TR199902963T2 (xx) 2000-02-21
TW570797B (en) 2004-01-11
CN1259050A (zh) 2000-07-05
TR200002790T2 (tr) 2001-11-21
CA2292629A1 (en) 1998-12-10
DZ2510A1 (fr) 2003-01-25
WO1998055122A1 (en) 1998-12-10
CN1526391A (zh) 2004-09-08
BG104048A (bg) 2000-07-31
NO995938L (no) 2000-02-02
AR015120A1 (es) 2001-04-18
ZA984826B (en) 1999-08-03
EA199901116A1 (ru) 2000-06-26
AR008198A1 (es) 1999-12-29
IL133074A0 (en) 2001-03-19
CO4940400A1 (es) 2000-07-24
NO995938D0 (no) 1999-12-03
HUP0004070A3 (en) 2002-03-28
HUP0004070A2 (hu) 2002-02-28
PE78899A1 (es) 1999-10-22
ID24264A (id) 2000-07-13
JP2001521553A (ja) 2001-11-06
GB9711683D0 (en) 1997-08-06
ZA9811572B (en) 1999-07-22
CN1430959A (zh) 2003-07-23
AP1214A (en) 2003-10-08
CA2333352A1 (en) 1998-12-10
OA11306A (en) 2003-10-22
PL337201A1 (en) 2000-08-14
NZ523725A (en) 2004-09-24
UY25032A1 (es) 1998-11-26
MXPA99011322A (es) 2004-12-02
EA002384B1 (ru) 2002-04-25

Similar Documents

Publication Publication Date Title
MA24171A1 (fr) Dihydrates de mesylate de 5- (2- (4-(1,2-benzisothiazole-3-yl) -1-piperazinyl)ethyl) -6-chloro-1,3-dihydro-2h-indole-2-one
NO20040738L (no) Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.
ID17504A (id) Mesilat trihidrat 5-(2-(4-1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-kloro-1,3-dihidro-2h-indol-2-on
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
DK0864582T3 (da) Hypolidemiske 1,4-benzothiazepin-1,1-dioxider
NO2009002I1 (no) 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid
NO20003069D0 (no) 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin- 2,4-dion-maleinsyre-salt-hydrat som farmasøytikum
DE59906902D1 (de) Herbizide 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidin-2,4-dione
FI911875L (fi) Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
ATE525362T1 (de) 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
MA25908A1 (fr) Chlorhydrate de 5-(4(2-(n-methyl-n-(2-pyridyl) amino) ethoxy) benzyl)thiazolidine-2,4-dione.
DE69630123D1 (en) Optische spaltung von 1-azabicylo(2.2.2)octan-3-amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methyl)
IT1313259B1 (it) Macchina per il montaggio di tomaia e sottopiede di una calzatura.
BR9805393B1 (pt) processo para preparar 2-(metiltio)-5-(trifluormetil)-1,3,4-tiadiazol usando metil ditiocarbazinato.
IL160144A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
TR199801735A3 (tr) 2-(arilfenil)amino-imidazolin türevleri.
NO20021986D0 (no) Natrium-2-(4,6-dimetyl-pyrimidin-2-yloksy)-3-(2-(3,4- dimetoksyfenyl)etoksy)-3,3-difenylpropionat og anvendelse deravsom endothelin-antagonist
HK1028191A (en) Composition comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazo lidine-2,4-dione
TR199700296U (tr) Hasat makinasi.
IT238107Y1 (it) Raviolatrice di affidabile funzionamento
FR2706262B1 (fr) Sac à dos, en particulier pour randonnées.
TR199802196A3 (tr) Heterosiklik bilesimler.
MA25138A1 (fr) 5-(2-ethyl-2h-tatrazole-5-yl)-methyle-1,2,3,6- tetrahydropuridine
IT1307974B1 (it) Cerniera elasticizzata per occhiali, con testa di snodo triangolare.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application